Principal Financial Group Inc Dyne Therapeutics, Inc. Transaction History
Principal Financial Group Inc
- $162 Billion
- Q1 2024
A detailed history of Principal Financial Group Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 15,403 shares of DYN stock, worth $638,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,403
Previous 14,546
5.89%
Holding current value
$638,762
Previous $193,000
126.42%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
180Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$333 Million28.49% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$325 Million31.49% of portfolio
-
Black Rock Inc. New York, NY5.39MShares$224 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$189 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$176 Million0.02% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $2.15B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...